-
1. SK Life Science Inc YKP3089 C021 Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects with Partial Onset Seizures
Objective: To evaluate the safety and pharmacokinetics of YKP3089 Inclusion criteria Age 14-65 Diagnosis of refractory focal epilepsy. No exact... -
2. Clobazam adjunctive treatment of adults with refractory focal epilepsy
Objective: to obtain pilot data on efficacy and safety of clobazam adjunctive treatment of adults Inclusion criteria Age 18-65 Refractory focal... -
3. Perampanel dual therapy anticonvulsant combination treatments of adults with refractory focal epilepsy.
Objective: to obtain pilot data on efficacy and safety of multiple different Perampanel dual therapy anticonvulsant combinatorial treatment of adults... -
4. Ketogenic diet treatment in refractory glioblastoma multiforme: a pilot study
Objective: to evaluate efficacy, safety and tolerability of ketogenic diet in patients with treatment resistant GBM Inclusion criteria Age... -
5. Ketogenic diet treatment adjunctive to radiation and chemotherapy in glioblastoma multiforme: a pilot study
Objective: to evaluate efficacy of ketogenic diet as adjunctive treatment of radiation treatment in glioblastoma multiforme Inclusion criteria Age... -
6. Human Epilepsy Project
Objective: To examine the relationship of clinical epilepsy characteristics, baseline neuroimaging features, electrophysiology, selected biomarkers,... -
An Evaluation of Epilepsy and Women’s Health Issues
An Evaluation of Epilepsy and Women’s Health Issues PI: Olgica Laban-Grant, M.D. Contact information: [email protected] This is...
The support That Sunovion Pharmaceuticals, Inc. has given the Private Practice Consortium is greatly appreciated.